|
ACER2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.748000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.435260E-03 |
| Normal-vs-Stage2 |
1.701220E-01 |
| Normal-vs-Stage3 |
6.748300E-02 |
| Normal-vs-Stage4 |
3.604500E-02 |
| Stage1-vs-Stage2 |
2.744600E-01 |
| Stage1-vs-Stage3 |
4.255800E-01 |
| Stage1-vs-Stage4 |
8.541200E-01 |
| Stage2-vs-Stage3 |
7.503800E-01 |
| Stage2-vs-Stage4 |
3.771800E-01 |
| Stage3-vs-Stage4 |
5.251200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.251000E-01 |
| Normal-vs-AfricanAmerican |
6.340300E-03 |
| Normal-vs-Asian |
6.376600E-01 |
| Caucasian-vs-AfricanAmerican |
4.839800E-01 |
| Caucasian-vs-Asian |
7.452600E-01 |
| AfricanAmerican-vs-Asian |
3.246000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.321400E-01 |
| Normal-vs-Female |
4.985800E-01 |
| Male-vs-Female |
3.416400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.896400E-02 |
| Normal-vs-Extreme_Weight |
2.30359999999763E-05 |
| Normal-vs-Obese |
1.418380E-02 |
| Normal-vs-Extreme_Obese |
1.440270E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.168390E-01 |
| Normal_Weight-vs-Obese |
8.762400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.868400E-01 |
| Extreme_Weight-vs-Obese |
1.198100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.083600E-01 |
| Obese-vs-Extreme_Obese |
3.690800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.184800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.583400E-04 |
| Normal-vs-Age(61-80Yrs) |
9.333000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.48399999960947E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.392800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.651800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.321870E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.808200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.51081999999469E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.112000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.208360E-04 |
| Normal-VS-Type2 PRCC |
2.609300E-04 |
| Normal-VS-KIRP CIMP |
7.048000E-02 |
| Normal-VS-Unclassified PRCC |
1.095370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.117400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.236500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.437500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.664800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.152200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.577700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.037830E-02 |
| Normal-vs-N1 |
9.831900E-02 |
| Normal-vs-N2 |
3.065800E-01 |
| N0-vs-N1 |
5.582800E-01 |
| N0-vs-N2 |
8.637000E-01 |
| N1-vs-N2 |
9.171200E-01 |
|
|
